Cargando…
Contralateral Effect following Intravitreal Brolucizumab Injection in Diabetic Macular Edema
The authors describe a novel case of a 48-year-old male with bilateral diabetic macular edema (DME) who underwent intravitreal injection (IVI) of brolucizumab in the left eye. At four weeks, the patient demonstrated a bilateral response by way of improvement in the best-corrected visual acuity (BCVA...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Hindawi
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8816604/ https://www.ncbi.nlm.nih.gov/pubmed/35127189 http://dx.doi.org/10.1155/2022/3755249 |